Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial by Lisa T Jansen (11876618)

“…</p> <p><b>Results: </b> Glucose metrics continued to decline after week 1 in HC-Starch and HC‑Sugar (p<0.05), but not VLC. From weeks 2-5, fasting and 2-hr glucose (mmol/L per week) decreased in HC-Starch (fasting: -0.10, p=0.001; 2-hr: -0.10, p=0.04). …”

Sleep alterations as a predictor of bipolar disorder among offspring of parents with bipolar disorder: a systematic review and meta-analysis by Kyara Rodrigues de Aguiar (12860786)

PyrrolylBODIPYs: Syntheses, Properties, and Application as Environment-Sensitive Fluorescence Probes by Changjiang Yu (319189)

“…These pyrrolylBODIPYs generally show intense absorption (centered at 570–624 nm) and fluorescence emission (582–654 nm) in nonpolar solvents. A gradual decrease in the fluorescence intensity was observed for these dyes with the increase in solvent dipolar moment, which combines with the red to far-red absorption/emission, rendering these pyrrolylBODIPYs potential applications as environment-sensitive fluorescence probes as demonstrated in this work for bovine serum albumin.…”

PyrrolylBODIPYs: Syntheses, Properties, and Application as Environment-Sensitive Fluorescence Probes by Changjiang Yu (319189)

“…These pyrrolylBODIPYs generally show intense absorption (centered at 570–624 nm) and fluorescence emission (582–654 nm) in nonpolar solvents. A gradual decrease in the fluorescence intensity was observed for these dyes with the increase in solvent dipolar moment, which combines with the red to far-red absorption/emission, rendering these pyrrolylBODIPYs potential applications as environment-sensitive fluorescence probes as demonstrated in this work for bovine serum albumin.…”

Impact Evaluation of a System-Wide Chronic Disease Management Program on Health Service Utilisation: A Propensity-Matched Cohort Study by Laurent Billot (838453)

“…These components were broadly prescribed by the head office of NSW Health, which funded the program, and were implemented by regional health services (local health districts) in ways that best suited their own history, environment, workforce, and patient need. We used a propensity-matched cohort study to evaluate health service utilisation after enrolment in the CDMP.…”

Celastrol is a potent p536 inhibitor. by Longjiang Shao (385841)

“…(<b>B</b>) VCaP cells were treated with different concentration of celastrol for 2 h. Significant decreased p536 expression was seen in all groups by western blot, including the lowest concentration group of 0.05 µM, strongly suggesting Celastrol is a potent p536 inhibitor. β-actin was the control.…”

Copeptin as a Serum Biomarker of Febrile Seizures by Benjamin Stöcklin (727398)

“…</p><p>Methods</p><p>This was a prospective emergency-setting cross-sectional study of 161 children between six months and five years of age. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

Light-Reconfiguring Inhomogeneous Soft Helical Pitch with Fatigue Resistance and Reversibility by Mengqi Li (2608237)

“…For the working model, the intrinsic chiral photoswitch <b>LBC5</b> is employed as an actuator to modulate the helical pitch length, which is proportional to the irradiation intensity, and the unique broadband absorbance photo-modulator <b>BTA-C5</b> is incorporated as an attenuator of the transmitted light to decrease its intensity along the sample thickness, therefore successfully adding another controlled DOF on the pitch length distribution (i.e., homogeneous or inhomogeneous) apart from the common soft helix with only a single DOF on the pitch length. …”

S1 File - by Aaliyah Momani (14768488)

“…<div><p>Background</p><p>COVID-19 hesitancy among women planning to become pregnant, who are pregnant, and who are breast-feeding is still a global phenomenon. Unfortunately, there is a lack of national educational programs that provide those groups of people with the information they need about the vaccine.…”

Zfp322a is required for ES pluripotency. by Hui Ma (290168)

“…<p>(<b>A</b>) <i>Zfp322a</i> mRNA level was decreased in mES cells cultured in LIF withdrawal ESC medium. …”

Supplementary Material for: The Association of Proteinuria Target Achievement Timing and Stability with Adverse Kidney Outcomes Among Patients with IgA Nephropathy: A Cohort Study by figshare admin karger (2628495)

“…We analyzed the association between those three metrics and the composite kidney outcome, which was defined as the first occurrence of either end-stage kidney disease (ESKD or a >50% decrease in eGFR from baseline. …”

Process map of a hematology patient in the ED. by Merahi Kefyalew Merahi (22208498)

“…</p><p>Results</p><p>Median LOS decreased by 62.5% (144–54 hours; p < 0.001), remaining stable during a 5-week pause. …”

Dapagliflozin: A Review in Type 1 Diabetes by Julia Paik (6912664)

“…As a highly selective SGLT2 inhibitor, dapagliflozin decreases plasma glucose levels independently of insulin action and enables glycaemic control improvement without increasing the risks associated with intensive insulin therapy. …”

sAxl levels in LN patients and healthy subjects. by Ioannis Parodis (2851211)

Supplementary Material for: Evaluating a Clinical Pathway in Laparoscopic Cholecystectomy: Effective in Reducing Complications? A Propensity Score Matching Analysis by Arabacioglu D. (8628537)